Habka Yurub ee 3′-Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9

Tayada First,iyo Client Supreme waa tilmaameheena si aan u gaarsiino gargaarka ugu fiican ee dukaameysanayaashayada. Maalmahan, waxaan isku daynay in aan ka mid noqono dhoofiyeyaasha ugu habboon gudaha garoonkayaga si aan u buuxinno macaamiisha dheeriga ah waxay u baahan doonaan qaabka Yurub ee 3′- Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9, In ​​ka badan 8 sano oo ganacsi yar, waxaan hadda uruurinay khibrad qani ah iyo tignoolajiyada horumarsan inta lagu gudajiro wax soo saarka alaabadayada.
Tayada Ugu Horaysa,iyo Macmiilka Sare waa hab-tilmaameedkeena si aanu u gaadhsiino caawimada ugu fiican ee wax iibsanaysaShiinaha 77-92-9 iyo CAS 77-92-9, Iyada oo ku saleysan khadkeena wax soo saarka tooska ah, kanaalka iibka alaabta joogtada ah iyo nidaamyada qandaraas-hoosaadka degdega ah ayaa laga dhisay dhul weynaha Shiinaha si loo daboolo baahida ballaaran ee macaamiisha sannadihii la soo dhaafay.Waxaan sugeynay inaan la shaqeyno macaamiil badan oo adduunka ah si aan u helno horumar guud iyo faa'iido wadaaga!Ilaalinta daacadnimada, hal-abuurka iyo hufnaanta, waxaan si dhab ah u filaynaa inaan noqon karno shuraakado ganacsi si aan u abuurno mustaqbalkeena quruxda badan!

2'-hydroxy-3'-nitro-3-biphenylcarboxylic acid waxaa loo isticmaalaa dhexdhexaadka Eltrombopag.
Eltrombopag, oo ay soo saartay GlaxoSmithKline (GSK) ee UK oo markii dambe si wadajir ah ula sameeyay Novartis ee Switzerland, waa kan ugu horreeya oo kaliya ee la ansixiyay molecule yar yar oo aan peptide TPO receptor agonist ee adduunka.Eltrombopag waxaa ansixiyay US FDA 2008 si loogu daweeyo idiopathic thrombocytopenic purpura (ITP), iyo 2014 ee daawaynta aplastic anemia daran (AA).Sidoo kale waa dawadii ugu horeysay ee ay ogolaato FDA US daawaynta AA 30kii sano ee la soo dhaafay.
Bishii Disembar 2012, US FDA waxay ansixisay Eltrombopag daaweynta thrombocytopenia ee bukaannada qaba cagaarshow C dabadheeraad ah (CHC), si bukaannada cagaarshowga C ee qaba saadaasha liidata sababtoo ah tirinta platelet hoose waxay bilaabi karaan oo ay ilaalin karaan interferon ku salaysan daaweynta caadiga ah ee cudurada beerka.Febraayo 3,2014, GlaxoSmithKline waxay ku dhawaaqday in FDA ay siisay shahaadada daawaynta dawaynta ee Eltrombopag ee daawaynta hemopenia ee bukaanada qaba buuga kiimikada daran aplastic anemia (SAA) kuwaas oo aan si buuxda uga jawaabin tallaalka.Agoosto 24, 2015, US FDA waxay ansixisay Eltrombopag daawaynta thrombocytopenia ee dadka waaweyn iyo carruurta da'doodu tahay 1 sano iyo ka weyn ee leh difaaca joogtada ah ee thrombocytopenia (ITP) kuwaas oo aan lahayn jawaab celin ku filan corticosteroids, immunoglobulins ama splenectomy.Janaayo 4, 2018, Eltrombopag waxaa loo ogolaaday in lagu daro Shiinaha si loogu daaweeyo trombocytopenia difaaca aasaasiga ah (ITP).

Tayada First,iyo Client Supreme waa tilmaameheena si aan u gaarsiino gargaarka ugu fiican ee dukaameysanayaashayada. Maalmahan, waxaan isku daynay in aan ka mid noqono dhoofiyeyaasha ugu habboon gudaha garoonkayaga si aan u buuxinno macaamiisha dheeriga ah waxay u baahan doonaan qaabka Yurub ee 3′- Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9, In ​​ka badan 8 sano oo ganacsi yar, waxaan hadda uruurinay khibrad qani ah iyo tignoolajiyada horumarsan inta lagu gudajiro wax soo saarka alaabadayada.
Yurub style forShiinaha 77-92-9 iyo CAS 77-92-9, Iyada oo ku saleysan khadkeena wax soo saarka tooska ah, kanaalka iibka alaabta joogtada ah iyo nidaamyada qandaraas-hoosaadka degdega ah ayaa laga dhisay dhul weynaha Shiinaha si loo daboolo baahida ballaaran ee macaamiisha sannadihii la soo dhaafay.Waxaan sugeynay inaan la shaqeyno macaamiil badan oo adduunka ah si aan u helno horumar guud iyo faa'iido wadaaga!Ilaalinta daacadnimada, hal-abuurka iyo hufnaanta, waxaan si dhab ah u filaynaa inaan noqon karno shuraakado ganacsi si aan u abuurno mustaqbalkeena quruxda badan!